Back
Supernus Pharmaceuticals Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
32
SUPN
Supernus Pharmaceuticals
Last Price:
$32.52
Seasonality Move:
11.77%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.87 | Sell |
| 20-day SMA: | 31.72 | Sell |
| 50-day SMA: | 31.89 | Sell |
| 200-day SMA: | 34.07 | Sell |
| 8-day EMA: | 31.89 | Sell |
| 20-day EMA: | 31.9 | Sell |
| 50-day EMA: | 32.47 | Sell |
| 200-day EMA: | 33.25 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.46 | Sell |
| Chaikin Money Flow: | -283596 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.99 - 32.37) | Sell |
| Bollinger Bands (100): | (31.4 - 37.44) | Sell |
Supernus Pharmaceuticals Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 31.54 while SUPN 8-day simple moving average is 31.87, which is a Sell signal.
-
The stock price of SUPN is 31.54 while Supernus Pharmaceuticals 20-day SMA is 31.72, which makes it a Sell.
-
Supernus Pharmaceuticals 50-day simple moving average is 31.89 while SUPN share price is 31.54, making it a Sell technically.
-
SUPN stock price is 31.54 and Supernus Pharmaceuticals 200-day simple moving average is 34.07, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
32
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a SellThe current Supernus Pharmaceuticals [SUPN] share price is $31.54. The Score for SUPN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.8B
Price in USD:
31.54
Share Volume:
423.2K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
25.53
Sell
32
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 31.54 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 31.54 while SUPN 8-day exponential moving average is 31.89, which is a Sell signal.
-
The stock price of SUPN is 31.54 while Supernus Pharmaceuticals 20-day EMA is 31.90, which makes it a Sell.
-
Supernus Pharmaceuticals 50-day exponential moving average is 32.47 while SUPN share price is 31.54, making it a Sell technically.
-
SUPN stock price is 31.54 and Supernus Pharmaceuticals 200-day simple moving average is 33.25, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.80 per share, and an increase next year of $0.52 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Supernus Pharmaceuticals is a Sell
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 46.46, which suggest Supernus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (30.99 - 32.37), which suggest Supernus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (31.4 - 37.44), which suggest Supernus Pharmaceuticals is a Sell
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.